Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 10, 1996, Pages 3483-3486

  De Roux, Nicolas ^a   Shields, Denis C ^b   Misrahi, Micheline ^a   Ratanachaiyavong, Suvina ^c,d   McGregor, Alan M ^d   Milgrom, Edwin ^a  

^a BICÊTRE HOSPITAL   (France)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR3 ANTIGEN; THYROTROPIN RECEPTOR;

ARTICLE; FAMILIAL DISEASE; GENE SEGREGATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GRAVES DISEASE; HLA TYPING; HUMAN; PRIORITY JOURNAL; RECEPTOR GENE;

ADOLESCENT; ADULT; FEMALE; GRAVES DISEASE; HLA-DR3 ANTIGEN; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN;

EID: 0029846159     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.10.3483     Document Type: Article

References (32)

1. DeGroot LJ, Quintans J. 1989 The causes of autoimmune thyroid disease. Endocr Rev. 10:537-562.
2. Rees Smith B, McLachlan SM, Furmaniak J. 1988 Autoantibodies to the thyrotropin receptor. Endocr Rev. 9:106-121.
3. Bartels ED. 1941 Heredity in Graves' disease. Munksgaard, Copenhagen.
4. Ratanachaiyavong S. 1992 Immunogenetics of Graves' disease in patients and their families. PhD thesis. London: King's College.
5. Aho K, Gordin A, Sievers K, Takala J. 1983 Thyroid autoimmuinity in siblings: a population study. Acta Endocrinol (Copenh). 251:11-15.
6. Stenszky V, Kozma L, Balazs C, et al. 1985 The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metah. 61:735-740.
7. Uno H, Sasazuki T, Tamai H, Matsumoto H. 1981 Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease. Nature. 292:768-770.
8. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M. 1995 CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab. 80:41-45.
9. Blakemore AIF, Watson PF, Weetman AP, Duff GW. 1995 Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab. 80:111-115.
10. Badenhoop K, Schwarz G, Schleusener H, et al. 1992 Tumor necrosis factor beta gene polymorphisms in Graves' disease. J Clin Endocrinol Metab. 74:287-291.
11. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF. 1992 Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab. 74:496-503.
12. Mangklabruks A, Cox N, DeGroot LJ. 1991 Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab. 73:236-244.
13. Allanic H, Fauchet R, Lorcy Y, et al. 1980 HLA and Graves' disease: an association with HLA-DRw3. J Clin Endocrinol Metab. 51:863-867.
14. Payami H, Joe S, Fand NR, et al. 1989 Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet. 45:541-546.
15. Shields DC, Ratanachaiyavong S, McGregor AM, Collins A, Morton NE. 1994 Combined segregation and linkage analysis of Graves' disease with a thyroid autoantibody diathesis. Am J Hum Genet. 55:540-554.
16. Morton NE, Shields DC, Collins A. 1991 Genetic epidemiology of complex genotypes. Ann Hum Genet. 55:301-314.
17. Mizukamui Y, Hashimoto T, Nonomura A, et al. 1994 Immunohistochemical demonstration of thyrotropin (TSH)-receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor protein. J Clin Endocrinol Metab. 79:616-619.
18. Utiger RD. 1995 Thyrotropin-receptor mutations and thyroid dysfunction. N Engl J Med. 332:155-60.
19. Bohr URM, Behr M, Loos U. 1993 A heritable point mutation in an extracellular domain of the TSH receptor involved in the interaction with Graves' immunoglobulins. Biochim Biophys Acta. 1216:504-508.
20. Sunthornthepvarakul T, Hayashi Y, Refetoff S. 1994 Polymorphism of a variant human thyrotropin receptor (hTSHR) gene. Thyroid. 4:147-149.
21. Bahn RS, Dutton CM, Heufelder AE, Sarkar G. 1994. A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophtalmopathy. J Clin Endocrinol Metab. 78:256-260.
22. Watson PF, French A, Pickerill AP, McIntosh RS, Weetman AP. 1995 Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves' disease. J Clin Endocrinol Metab. 80:1032-1035.
23. Cuddihy RM, Dutton CM, Bahn RS. 1995 A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid. 5:89-95.
24. Gross B, Misrahi M, Sar S, Milgrom E. 1991 Composite structure of the human thyrotropin receptor gene. Biochem Biophys Res Commun. 177:679-687.
25. de Roux N, Misrahi M, Chatelain N, Milgrom E. 1996 Three microsatellites localised within the human TSH receptor gene: characterisation and genetic localisation. Mol Cell Endocrinol. 117:253-256.
26. Weetman AP, McGregor AM. 1994 Autoimmune thyroid disease: further developments in our understanding. Endocr Rev. 15:788-830.
27. Ratanachaiyavong S, Lloyd L, Darke C, McGregor AM. 1993 MHC-extended haplotypes in families of patients with Graves' disease. Hum Immunol. 36:99-111.
28. Howel Evans AW, Woodrow JC, McDougall CDM, Chew AR, Winston Evans R. 1967 Antibodies in the families of thyrotoxic patients. Lancet. 1:636-641.
29. Lander ES, Schork JN. 1994 Genetic dissection of complex traits. Science. 265:2037-2048.
30. Kosugi S, Ban T, Kohn LD. 1993 Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. Mol Endocrinol. 7:114-130.
31. Goodnow CC, Adelstein S, Basten A. 1990 The need for central and peripheral tolerance in the B cell repertoire. Science. 248:1373-1379.
32. Weeks DE, Lange K. 1988 The affected pedigree member method of linkage analysis. Am J Hum Genet. 42:315-326.